The anti-infective medicine market in the UK shows a steady growth trajectory from 2024 to 2028, with sales forecasted to rise from 4.58 billion USD PPP in 2024 to 4.99 billion USD PPP by 2028. The year-on-year growth rate maintains a consistent pattern of around 2.2% annually from 2025 onwards. Before these projections, the 2023 sales stood close to 4.5 billion USD PPP. Looking at the compound annual growth rate (CAGR), it is expected to average approximately 2.17% over the five-year forecast period.
Future trends to watch for include:
- Innovations and advancements in anti-infective drugs.
- Regulatory changes impacting market dynamics.
- Effects of global events on supply chains and pricing.
- Shifts in public health policies and spending.
